AUG 28, 2026 · JOURNAL ARTICLE
Molecular epidemiology and antimicrobial resistance of human Streptococcus suis isolates in Guangxi, China, 2015–2021
Frontiers in Public Health
A regional descriptive epidemiological and genomic characterization of 39 confirmed S. suis isolates with no control group, clinical trial, or intervention, providing surveillance data that informs but does not change clinical practice directly.
Reported
Sample size39
Tetracycline resistance rate92.7%
Erythromycin resistance rate62.5%